Skip to content

PTC Therapeutics

US · PTCT #2071 by market cap Listed 1970
56.42 -1.91 -3.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
D+
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
3 3
■ Upgrades■ Downgrades
  • 3 upgrades vs 3 downgrades among tracked analyst rating changes.
  • Most recent: Truist Financial moved from Buy to Hold on 2026-10-16.

Analyst consensus 12 analysts

Buy
Avg price target 100.00 +77.2%
Price target rangecurrent 56.42
Low62.00
Avg100.00
High137.00
Buy 83% Hold 17% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-05 J.P. Morgan -- Buy 92.00
2026-11-02 Citi -- Buy 109.00
2026-11-02 Barclays -- Buy 122.00
2026-11-02 J.P. Morgan -- Buy 92.00
2026-10-30 TD Cowen -- Buy 95.00
2026-10-30 Wells Fargo -- Buy 112.00
2026-10-30 UBS -- Buy 90.00
2026-10-30 BofA Securities -- Buy --
2026-10-29 Cantor Fitzgerald -- Buy 137.00
2026-10-29 RBC Capital -- Hold 77.00
2026-10-27 RBC Capital -- Hold 75.00
2026-10-20 Raymond James -- Buy 106.00
2026-10-19 Wells Fargo -- Buy 109.00
2026-10-16 UBS -- Buy 90.00
2026-10-16 Truist Financial -- Hold 62.00
2026-10-15 UBS -- Buy 90.00
2026-10-14 UBS -- Buy 90.00
2026-10-14 J.P. Morgan -- Buy --
2026-10-09 BofA Securities -- Buy --
2026-10-07 Barclays -- Buy 122.00
2026-10-07 RBC Capital -- Hold 75.00
2026-09-21 Cantor Fitzgerald -- Buy 137.00
2026-09-14 Leerink Partners -- Buy 98.00
2026-09-02 Wells Fargo -- Buy 109.00
2026-08-30 TD Cowen -- Buy 90.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-10-16 Truist Financial Buy → Hold 62.00
2026-06-09 Citi Hold → Buy 108.00
2026-05-27 Jefferies Hold → Buy 85.00
2026-05-08 TD Cowen Hold → Buy 90.00
2026-03-30 Jefferies Buy → Hold 76.00
2025-12-01 RBC Capital Buy → Hold 91.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-29 After close ±14.05% -6.97% (in line)
2026/Q2 2026-07-30 After close ±10.56% -9.94% (in line)
2026/Q1 2026-05-07 After close ±9.33% +14.27% (beat)
2025/Q4 2026-02-19 After close ±8.61% +1.09% (in line)
2025/Q3 2025-11-04 After close ±11.26% +5.98% (in line)
2025/Q2 2025-08-07 After close ±11.28% -9.89% (in line)
2025/Q1 2025-05-06 After close ±12.41% +12.63% (beat)
2024/Q4 2025-02-27 After close ±20.21% +9.27% (in line)
2024/Q3 2024-11-07 After close ±9.43% +3.07% (in line)
2024/Q2 2024-08-08 After close ±13.77% -3.57% (in line)
2024/Q1 2024-04-25 After close ±20.29% +12.08% (in line)
2023/Q4 2024-02-29 After close ±18.20% +13.34% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

PTC Therapeutics discussion 0 comments

Add a comment